I heard the US has now an accelerated process along with...

I heard the US has now an accelerated process along with standard and priority for FDA approval.

While the whingers here will probably moan , it might be possible TIS will get an accelerated process if the product significantly improves the quality of life of patients
As for dilution or up and downs look at NRT over tme or the 112% dilution of NWT although that is a tech stock not biomedical -
If it gets up and running we will make money, without it we are sunk.

So good result I think, just that TIS could inform the market a little more except they do not have much to report. Waiting game now isn't it?

I probably will take my. 10 for one offerring